Lung Cancer Clinical Trial
Official title:
An Imaging Study to Compare Methods to Reduce 4DCT Image Acquisition Artifacts
The goal of this clinical research study is to learn about ways to possibly reduce scanning errors when using 4-dimensional computed tomography (4D CT) scans to check lung function in patients with esophageal or lung cancer.
Study Procedure:
By using 4D CT scans, researchers can create images that show how air moves through the
lungs. This new method to check lung function may make better images than the standard
methods. Researchers will compare 4 images of how air moves through your lungs and 1 image
while you hold your breath.
Study Groups:
If you are found to be eligible to take part in this study (if the screening test is
applicable) and you agree to take part in this study, you will be enrolled in 1 of 2 study
groups, depending on when you join the study. There will be up to 18 participants in each
group. In the first group, researchers will test several different methods to create images
of how air moves through the lungs. Researchers will then select the most successful methods
from the first group and try to do them again with the second group.
Study Visits:
You will have up to two visits for this study. At these visits, you will have four 4DCT
scans performed (for Group 1) or five scans (for Group 2) using both the 4DCT and spiral CT,
while you are breathing normally. You will also have 1 scan while you hold your breath for
less than 20 seconds. The CT scans will take about 5 minutes each to complete. If the spiral
CT scans for Group 2 cannot be completed on the same day as the 4DCT scans, you will be
asked for your willingness to return at a later day to complete these.
The 4D CT scan will cover the entire chest area using the standard dose of radiation. A
2-inch plastic box will be placed on top of your chest to track the motion of your chest
while you breathe during each scan. Some parts of your chest will be scanned up to 2 more
times based on your breathing.
The entire scanning session will take about 45 minutes to complete.
Length of Participation:
Your active participation on the study will be over when you have completed your study
visit.
Follow-Up Phone Call:
Within 7 days after your last study visit, the study staff will call you to ask about any
side effects you may be having. This call should last about 2 minutes.
If anything unusual is found in the imaging, your cancer doctor will be told so that you can
receive follow-up.
This is an investigational study. The CT scans used in this study are delivered using
FDA-approved and commercially available systems. Creating images of how air moves through
the lungs from 4D CT scans is considered investigational.
Up to 36 patients will take part in this study. All will be enrolled at M. D. Anderson.
;
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03918538 -
A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors
|
N/A | |
Recruiting |
NCT05078918 -
Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors
|
N/A | |
Active, not recruiting |
NCT04548830 -
Safety of Lung Cryobiopsy in People With Cancer
|
Phase 2 | |
Completed |
NCT04633850 -
Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
Not yet recruiting |
NCT06376253 -
A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
|
Phase 1 | |
Recruiting |
NCT05898594 -
Lung Cancer Screening in High-risk Black Women
|
N/A | |
Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
Active, not recruiting |
NCT03575793 -
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
|
Phase 1/Phase 2 | |
Terminated |
NCT01624090 -
Mithramycin for Lung, Esophagus, and Other Chest Cancers
|
Phase 2 | |
Terminated |
NCT03275688 -
NanoSpectrometer Biomarker Discovery and Confirmation Study
|
||
Not yet recruiting |
NCT04931420 -
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
|
Phase 2 | |
Recruiting |
NCT06052449 -
Assessing Social Determinants of Health to Increase Cancer Screening
|
N/A | |
Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
Not yet recruiting |
NCT06017271 -
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
|
||
Recruiting |
NCT05787522 -
Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
|